Sat, Jun 23, 2018
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Valeant Welcomes John Paulson’s $1bn stake in Allergan

Wednesday, July 02, 2014

Komfie Manalo, Opalesque Asia:

Valeant Pharmaceuticals Inc's chief executive Michael Pearson on Thursday welcomed news that hedge fund manager John Paulson through his firm, Paulson & Co., is building a $1bn stake in Allergan, Reuters said.

Deal-making drug-maker Valeant has partnered with activist hedge fund manager Bill Ackman of Pershing Square to acquire Allergan and shake up its board.

In an interview with Canada's BNN TV, Pearson said he was delighted with Paulson’s move to buy six million shares at Allergan. "We do believe we'll get the 25 percent and the majority we need to get this deal consummated," he was quoted as saying.

According to the report, Paulson’s position, together with Pershing Square’s stocks, are sufficient to provide the group with a 25% support of Allergan shares required to call the special meeting to replace majority of Allergan’s current sitting board.

On Wednesday, Paulson announced he has built a $1bn stake in Allergan and supports a takeover of the Botox maker by Valeant. Paulson's position is a boost to Valeant and its partner in the hostile bid, Ackman. Valean......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Paper: The performance of stocks actively pitched by hedge funds[more]

    Using a novel dataset drawn from investment conferences from 2008 to 2013, I show that hedge funds take advantage of the publicity of these conferences to strategically release their book information to drive market demand. Specifically, hedge funds sell pitched stocks after the conferences to ta

  2. North America - US fundraising for special purpose acquisition vehicles hits record this year[more]

    From AFR.com: Special purpose acquisition vehicles (spacs) are hitting the US market at the fastest rate on record, attracting the likes of Goldman Sachs and hedge fund investor Daniel Loeb for the two largest such deals in 2018. Spacs have raised $US4.5bn so far in 2018, the largest amount fo

  3. Investing - Man Group and AQR try to take aim at private equity industry, Hedge funds poised to be winners in AT&T-Time Warner deal[more]

    Man Group and AQR try to take aim at private equity industry From FT.com: The popularity of private equity investments has prompted asset managers such as Man Group and AQR to devise strategies that aim to replicate PE returns but at a much lower cost to investors. Both companies a

  4. News Briefs: David Stemerman's hedge fund holdings shrank before his run for governor, nvestment manager TSW triggers succession plan, Alan Howard joins Peter Thiel investing in Cologne-based fintech startup[more]

    David Stemerman's hedge fund holdings shrank before his run for governor But the U.S. holdings of Stemerman's Greenwich hedge fund, Conatus Capital, shrank from $2.6 billion at the apex to just over $1 billion before he announced his move into politics. (Hartford Courant) Inv

  5. British Empire: Pershing's 23% discount 'unsustainable'[more]

    From Citywire: The wide discount on Pershing Square Holdings (PSH) is 'unsustainable' and puts star hedge fund manager Bill Ackman under pressure, says British Empire (BTEM). Pershing is the third largest holding in the £850 million British Empire trust, managed by Joe Bauernfreund, which sp